Autonomic Nervous System Drugs Practice Questions

Q: Which of the following muscle relaxants is a depolarizing agent?

Succinylcholine. ***Succinylcholine*** - **Succinylcholine** is the only **depolarizing neuromuscular blocker** in common clinical use, acting as an acetylcholine receptor agonist. - It works by initially causing muscle fasciculations (depolarization) followed by **sustained muscle paralysis** (desensitization phase). *Rocuronium* - **Rocuronium** is a **nondepolarizing neuromuscular blocker**. - It acts as a **competitive antagonist** at the nicotinic acetylcholine receptors at the neuromuscular junction, preventing acetylcholine from binding. *Vecuronium* - **Vecuronium** is also a **nondepolarizing neuromuscular blocker**. - It competes with acetylcholine for binding sites on the **nicotinic receptors** at the motor end plate without activating them. *Atracurium* - **Atracurium** is another **nondepolarizing neuromuscular blocker**. - Its mechanism involves **competitive antagonism** of acetylcholine at the neuromuscular junction, leading to muscle relaxation.

Q: A 30-year-old male is diagnosed with myasthenia gravis. Which of the following drugs is commonly used for the symptomatic treatment of myasthenia gravis?

Pyridostigmine. ***Pyridostigmine*** - **Pyridostigmine** is an **acetylcholinesterase inhibitor** that increases the amount of acetylcholine available at the neuromuscular junction, improving muscle strength. - It is considered a cornerstone for **symptomatic treatment** of myasthenia gravis, providing temporary relief from weakness. *Atropine* - **Atropine** is a **muscarinic acetylcholine receptor antagonist** and would worsen myasthenia gravis by blocking acetylcholine's effects at muscarinic receptors. - It is sometimes used to counteract the **side effects** of acetylcholinesterase inhibitors (e.g., bradycardia, increased secretions), but not for the primary treatment of myasthenia gravis. *Cyclobenzaprine* - **Cyclobenzaprine** is a **skeletal muscle relaxant** used to treat muscle spasms, not the weakness associated with autoimmune conditions like myasthenia gravis. - Its mechanism involves effects on the central nervous system, and it has no direct role in improving **neuromuscular transmission** in myasthenia gravis. *Diazepam* - **Diazepam** is a **benzodiazepine** primarily used for anxiety, seizures, and muscle spasms, acting as a CNS depressant. - It does not address the underlying **neuromuscular junction defect** in myasthenia gravis and can even worsen muscle weakness due to its sedative effects.

Q: Which of the following agents is associated with maximum histamine release?

d-Tubocurarine. ***d-Tubocurarine*** - This **non-depolarizing neuromuscular blocker** is known for its significant potential to cause **histamine release** [2], [3], [4]. - Histamine release can lead to undesirable side effects such as **hypotension**, **tachycardia**, and **bronchospasm** [2], [3]. *Cisatracurium* - Cisatracurium is a **benzylisoquinolinium neuromuscular blocker** that is known for its minimal to no histamine release. - Its degradation through **Hofmann elimination** contributes to its favorable cardiovascular profile. *Pancuronium* - Pancuronium is an **aminosteroid neuromuscular blocker** that has a low incidence of histamine release [1]. - It can cause a **vagolytic effect**, leading to an increase in heart rate [2], [3]. *Rocuronium* - Rocuronium is another **aminosteroid neuromuscular blocker** that is associated with very minimal histamine release [2]. - It is often favored in situations where a **rapid onset** is required, such as in rapid sequence intubation.

Q: Oxybutynin acts by which mechanism?

Muscarinic receptor antagonist. ***Muscarinic receptor antagonist*** - **Oxybutynin** is an **anticholinergic** agent that acts primarily as a competitive antagonist at **muscarinic acetylcholine receptors**, especially M3 receptors in the bladder. - By blocking these receptors, it relaxes the **detrusor muscle**, thereby reducing involuntary contractions and treating symptoms of **overactive bladder**. *Adrenergic receptor antagonist* - Adrenergic receptor antagonists (like **beta-blockers** or **alpha-blockers**) target epinephrine and norepinephrine receptors, which are involved in sympathetic nervous system responses. - These drugs are used for conditions like hypertension or benign prostatic hyperplasia, and their mechanism of action is distinct from oxybutynin's effect on muscarinic receptors. *Histaminic antagonist* - Histaminic antagonists (like **antihistamines**) block histamine receptors and are commonly used to treat allergic reactions or insomnia. - Oxybutynin does not primarily act on histamine receptors, although some anticholinergics can have mild antihistaminic properties. *Serotonergic antagonist* - Serotonergic antagonists block serotonin receptors and are used for conditions such as migraine, nausea, or psychiatric disorders. - Oxybutynin's therapeutic effects are not mediated through antagonism of serotonin receptors.

Q: Which of the following conditions is treated with botulinum toxin?

All of the options. **All of the options** - **Botulinum toxin** is widely used in medicine to treat various conditions characterized by **muscle overactivity** or excessive glandular secretion. - Its mechanism of action involves blocking the release of **acetylcholine** at neuromuscular junctions or nerve endings, leading to muscle paralysis or reduced glandular activity. *Axillary hyperhidrosis* - **Botulinum toxin** is an effective treatment for **severe primary axillary hyperhidrosis**, which is characterized by excessive sweating in the armpits. - It works by blocking the release of **acetylcholine** from sympathetic nerves that stimulate sweat glands, thereby reducing sweat production. *Blepharospasm* - **Blepharospasm** is a focal dystonia characterized by **involuntary twitching or sustained contractions** of the muscles around the eyes, leading to forceful eyelid closure. - **Botulinum toxin injections** into the orbicularis oculi muscle weaken the excessive muscle contractions, providing symptomatic relief. *Cervical dystonia* - **Cervical dystonia** (also known as spasmodic torticollis) involves **involuntary contractions of neck and shoulder muscles**, causing the head to twist or turn abnormally. - **Botulinum toxin injections** into the affected neck muscles help relax them, reducing pain and abnormal posturing.

Q: Advantage of glycopyrrolate over atropine is?

It lacks central nervous system penetration. ***It lacks central nervous system penetration.*** - **Glycopyrrolate** is a **quaternary ammonium compound** and is highly ionized, which prevents it from crossing the **blood-brain barrier**. - This characteristic significantly reduces the risk of **CNS side effects** such as sedation, confusion, or delirium, which are commonly associated with **atropine**. *It is a natural alkaloid* - **Atropine** is a **natural alkaloid** derived from plants like *Atropa belladonna*, whereas **glycopyrrolate** is a synthetic compound. - Being a natural alkaloid does not confer an advantage in terms of selective action or side effect profile. *Can be used in OPC poisoning* - Both **atropine** and **glycopyrrolate** can be used in the treatment of **organophosphate poisoning (OPC)** due to their anticholinergic properties. - However, **atropine** is generally preferred in acute OPC poisoning for its ability to reverse both peripheral and central muscarinic effects. *Is more potent* - While both are **antimuscarinic agents**, their potency can vary depending on the specific receptor subtype or clinical effect. - Glycopyrrolate is often cited for its potent **antisialagogue** (reducing saliva) effect, but atropine is more potent at blocking cardiac vagal effects.

Q: What is the mechanism of action of metyrosine?

Tyrosine hydroxylase. ***Tyrosine hydroxylase*** - **Metyrosine** acts as a **competitive inhibitor** of **tyrosine hydroxylase**, which is a crucial enzyme in the **catecholamine synthesis pathway**. - By blocking this rate-limiting step, metyrosine reduces the production of **dopamine**, **norepinephrine**, and **epinephrine**. *Phenylethanolamine N-methyltransferase* - This enzyme converts **norepinephrine to epinephrine** and is not the primary target of metyrosine. - While metyrosine indirectly affects downstream products, its direct action is not on this enzyme. *Phenylalanine hydroxylase* - This enzyme converts **phenylalanine to tyrosine** and is associated with conditions like **phenylketonuria**. - It is not involved in the direct synthesis of catecholamines from tyrosine, nor is it the target of metyrosine. *Tyrosinase* - **Tyrosinase** is involved in the synthesis of **melanin**, not catecholamines. - Inhibition of this enzyme would primarily affect pigmentation, which is unrelated to metyrosine's therapeutic use.

Q: Tachyphylaxis is seen with which of the following drugs?

Ephedrine. ***Ephedrine*** - **Ephedrine** is an indirectly acting sympathomimetic that releases stored norepinephrine from nerve terminals [1, 3]. This can lead to **tachyphylaxis** (rapidly decreasing response to repeated doses) as **norepinephrine stores** become depleted [2, 3]. - Due to the depletion of **neurotransmitter stores**, subsequent doses become less effective until stores are replenished [2, 3]. *Pethidine* - **Pethidine** is an opioid analgesic; its primary mechanism of action involves agonizing opioid receptors. - It does not typically exhibit **tachyphylaxis** through neurotransmitter depletion, but rather can lead to tolerance with chronic use. *Phenoxybenzamine* - **Phenoxybenzamine** is a non-selective, **irreversible alpha-adrenergic receptor blocker**. - Its mechanism involves long-lasting blockade of receptors, and **tachyphylaxis** is not a characteristic feature of its pharmacodynamics. *Phentolamine* - **Phentolamine** is a non-selective, **reversible alpha-adrenergic receptor blocker**. - While it has a shorter duration of action compared to phenoxybenzamine, its effects are reversible and it does not typically cause **tachyphylaxis** through neurotransmitter depletion.

Q: Which of the following statements about the action of anticholinergic drugs is false?

Atropine causes bronchoconstriction. ***Atropine causes bronchoconstriction*** - Atropine is an **anticholinergic drug** that blocks muscarinic receptors (M3) in the bronchi, leading to **bronchodilation**, not bronchoconstriction. - Bronchoconstriction is typically mediated by **acetylcholine** acting on M3 receptors, which atropine inhibits. *Atropine is a CNS stimulant* - While atropine primarily acts peripherally, higher doses can cross the **blood-brain barrier** and cause central nervous system effects, including initial stimulation followed by depression in severe overdose. - Initial stimulation can manifest as **restlessness**, **agitation**, and even hallucinations. *Atropine can increase the chances of hyperthermia in children* - Atropine inhibits **sweat gland activity** by blocking muscarinic receptors (M3), which can impair heat dissipation. - This effect, particularly in children who have a less developed thermoregulatory system, can lead to **atropine fever** or hyperthermia. *Atropine causes mydriasis, abolition of light reflex and cycloplegia* - Atropine blocks **muscarinic receptors** (M3) in the iris sphincter muscle, causing **mydriasis** (pupil dilation). - It also paralyzes the ciliary muscle (M3 receptor blockade), leading to **cycloplegia** (loss of accommodation) and abolition of the light reflex.

Question 1

Which of the following muscle relaxants is a depolarizing agent?

Accepted Answer

Succinylcholine

Answer

Rocuronium

Answer

Vecuronium

Answer

Atracurium

Question 2

A 30-year-old male is diagnosed with myasthenia gravis. Which of the following drugs is commonly used for the symptomatic treatment of myasthenia gravis?

Accepted Answer

Pyridostigmine

Answer

Atropine

Answer

Cyclobenzaprine

Answer

Diazepam

Question 3

A patient presents with a rapid onset of muscle weakness after starting a new medication. Which physiological mechanism should be primarily investigated?

Accepted Answer

Acetylcholine receptor blocking

Answer

Sodium channel blocking

Answer

Potassium channel activation

Answer

Calcium channel enhancement

Question 4

Which of the following agents is associated with maximum histamine release?

Accepted Answer

d-Tubocurarine

Answer

Pancuronium

Answer

Rocuronium

Answer

Cisatracurium

Question 5

Oxybutynin acts by which mechanism?

Accepted Answer

Muscarinic receptor antagonist

Answer

Adrenergic receptor antagonist

Answer

Histaminic antagonist

Answer

Serotonergic antagonist

Question 6

Which of the following conditions is treated with botulinum toxin?

Accepted Answer

All of the options

Answer

Blepharospasm

Answer

Axillary hyperhidrosis

Answer

Cervical dystonia

Question 7

Advantage of glycopyrrolate over atropine is?

Accepted Answer

It lacks central nervous system penetration

Answer

It is a natural alkaloid

Answer

Can be used in OPC poisoning

Answer

Is more potent

Question 8

What is the mechanism of action of metyrosine?

Accepted Answer

Tyrosine hydroxylase

Answer

Phenylethanolamine N-methyltransferase

Answer

Phenylalanine hydroxylase

Answer

Tyrosinase

Question 9

Tachyphylaxis is seen with which of the following drugs?

Accepted Answer

Ephedrine

Answer

Pethidine

Answer

Phenoxybenzamine

Answer

Phentolamine

Question 10

Which of the following statements about the action of anticholinergic drugs is false?

Accepted Answer

Atropine causes bronchoconstriction

Answer

Atropine is a CNS stimulant

Answer

Atropine can increase the chances of hyperthermia in children

Answer

Atropine causes mydriasis, abolition of light reflex and cycloplegia

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?